Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline (Q28274642)
Jump to navigation
Jump to search
scientific article
- Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline |
scientific article |
|
Statements
Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline (English)
0 references
Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder (English)
1 reference
Françoise Picarel-Blanchot
0 references
Enrico Smeraldi
1 reference
25 March 2017
Janusz K. Rybakowski
1 reference
Göran Hajak
1 reference
Katharina Wulff
1 reference
Angel Luis Montejo
1 reference
Maria-Antonia Quera-Salva
1 reference
Françoise Picarel-Blanchot
1 reference
Witte J. G. Hoogendijk
1 reference
Anna M. Wirz-Justice
1 reference
Franck J. Baylé
1 reference
February 2010
0 references
15 February 2010
1 reference
71
1 reference
2
0 references
02
1 reference
109-20
0 references
109-120
1 reference
Identifiers
1 reference